Friday, 28 Feb 2020


Datesort ascending Type Title Save
30 Oct 2019 Social Persistently frequent use of emergency department (ED) by lupus patients was primarily for pain by SLE pts who were more apt to be on narcotics. Pain management in SLE appears to be a significant challenge, if not unmet need.
29 Oct 2019 Social UTSW retrospective study of 118 Cutaneous LE patients without prior SLE (13 SCLE; 105 chronic CLE; 87 DLE) , finds 12.7% with prior-onset autoimmune dz (thyroid, Sjogrens, etc) . M median time from CLE Dx to new autoimmune disease was 7.3 yrs
17 Oct 2019 News Protective Effects of ASA and Vasodilators in Systemic Sclerosis
16 Oct 2019 Social Single center study of anti-PhosphoLipd Abs in 149 Bx proven lupus nephritis pts 36% had APL Abs (18.8% IgG, 18.1% IgM, 10.7% B2GlyP, 8.1% LAC). F/U of 156 mos - APL+ had lower 10 yr survival (91 vs 99%). lower GFR, more thrombotic events & miscarriage
16 Oct 2019 News Myositis Patients at High Risk of Opportunistic Infections
15 Oct 2019 News Warfarin Superior to Xarelto in Antiphospholipid Syndrome
14 Oct 2019 Social Comparison of 69 SLE pts w/ C/S+ infection vs 69 SLE without infx shows that serum procalitonin did not distinguish those w/ infection, BUT C-reactive protein did successfully identify those SLE patients with infection
14 Oct 2019 Social Taiwanese Claims data study shows the risk of opportunistic infection in ~77K autoimmune pts shows OI highes in PM/DM cases (61.3/1000PY), followed by SLE (43.1/1000PY), SSc (31.6), RA (25), and pSS (24.1). OI risk highest during 1st year
09 Oct 2019 News Declining Trends in Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis Mortality in the USA
08 Oct 2019 News Serum Interferon Predicts Lupus Flares
07 Oct 2019 Social T2T in Lupus Nephritis aims for less proteinuria, Study of 87 pts with class III/IV LN compared goal of urine protein/creat ratio(UPCR) < 0.5 to stringent < 0.15, Latter assoc w/ lower renal flares (HR  0.16), less CKD (HR 0.19), more MMF use (HR = 7.26)
05 Oct 2019 Social RT @LCalabreseDO: Looking forward to giving plenary talk at #ACR2019 at 11AM Sunday on practical aspects of vaccines(flu/pneumo/VZV) for au…
04 Oct 2019 News ILD Patients At Risk for Autoimmune Disease
01 Oct 2019 Social Kaiser study of 1956 SLE patients shows only 58% of were adherent (≥ 80%) to hydroxychloroquine; not predicted by the Rheum, hospital or socioeconomics. Risk factors for nonadherence included age, being white, # of Rheum visits/yr.
30 Sep 2019 Social A&R reviews the inflammasome in autoimmune diseases. Pattern recognition recpt induce inflammasome activation, pro-caspase-1 converts to caspase-1 convertin pro-IL-1β and pro-IL-18 active IL-1β and IL-18; seen in RA, SLE, gout, Sjogrens
28 Sep 2019 Social The RheumNow Podcast is up - discussing PSS & Cancer, SLE & narcotics, AAV & Lipids, Anakinra & NIDDM. Watch it here>> or listen to the podcast on iTunes, or SoundCloud>>
26 Sep 2019 News MMWR: Increased Opioid Use in Lupus
25 Sep 2019 News Low Dose IL-2 Effective in Lupus
20 Sep 2019 Social 90 SLE pts (SLEDAI<6) on immunosuppressives were given PBO or Live Virus zostavax - Vax pts had significantly higher Wk 6 anti-VZV IgG, more injection site reactions (31 vs 7%). 3 pts flared (1PBO; 2 Zostavax) and no one developed zoster postvaccination
20 Sep 2019 Social Risk of HCQ/CQ Retinal toxicity was 5.5% in 326 SLE pts F/U x 12.8 yrs. None occured in 1st 5 yrs; earliest 8 yrs (max =33 years). Retinal toxicity cases tended to have more renal disease (22% vs 15%) and were slightly less likely to be Caucasian